BNP Paribas Financial Markets’s Sanara MedTech SMTI Stock Holding History

BNP Paribas Financial Markets’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$336K	Sell	14,239 -13,459	-49%	-$278K	﹤0.01%	3973
2026 Q1	$476K	Buy	27,698 +23,349	+537%	+$480K	﹤0.01%	3616
2025 Q4	$102K	Buy	4,349 +2,845	+189%	+$73.5K	﹤0.01%	4369
2025 Q3	$47.7K	Buy	1,504 +1,171	+352%	+$35.4K	﹤0.01%	4619
2025 Q2	$9.45K	Buy	333 +75	+29%	+$2.25K	﹤0.01%	4856
2025 Q1	$7.96K	Sell	258 -2,947	-92%	-$100K	﹤0.01%	4776
2024 Q4	$106K	Buy	+3,205	New	+$109K	﹤0.01%	4143

Other funds holding SMTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BNP Paribas Financial Markets's SMTI Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Sanara MedTech (SMTI) stake by 49% in Q2 2026, selling an estimated $278K and leaving 14,239 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #3973.

BNP Paribas Financial Markets first reported a position in SMTI in Q4 2024 and has held it in 7 quarters since. The position peaked at $476K in Q1 2026. 70 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

BNP Paribas Financial Markets held 14,239 shares of Sanara MedTech worth $336K as of Q2 2026.
BNP Paribas Financial Markets sold 13,459 Sanara MedTech shares in Q2 2026, an estimated $278K.
Sanara MedTech made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3973 holding.
BNP Paribas Financial Markets first reported a position in Sanara MedTech in Q4 2024 and has held it in 7 quarters since.
BNP Paribas Financial Markets's Sanara MedTech position peaked at $476K in Q1 2026.
70 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.